Literature DB >> 7835212

HLA, ESD, GLOI, C3 and HP polymorphisms and juvenile insulin dependent diabetes mellitus in Tamil Nadu (south India).

V S Subramanian1, C V Krishnaswami, C Damodaran.   

Abstract

Fifty juvenile insulin dependent diabetes mellitus (JIDDM) patients of Tamil Nadu (South India) were typed for HLA-A, -B, -C, -DR, and -DQ, ESD, GLOI, C3 and HP polymorphisms. The frequencies of B8, DR3, DR4, DR53 and DQ2 antigens of the HLA system were significantly higher in the patients than in controls (relative risk, RR = 4.81; 5.14; 3.98; 3.36 and 2.53, respectively). However HLA-DR2, -DR5 and -DQ1, observed less frequently in the patient group, appear to play a role of protection against the disease (RR = 0.32; 0.30 and 0.20 respectively). HLA haplotype analysis demonstrated very high relative risk associated with two hitherto unreported haplotypes namely A3,DR1 and Cw3,DR4 (RR = 27.30 and 20.00, respectively) and also scanty distribution of the haplotypes A1,B17 and DR2,DQ1 (RR = 0.39 and 0.36, respectively) in the patient group. Among other genetic markers tested, GLOI is informative with its phenotype GLOI 2-1 showing positive association with JIDDM (RR = 4.06).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7835212     DOI: 10.1016/0168-8227(94)90161-9

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  2 in total

1.  Distribution of glyoxalase I polymorphism among Zuni Indians: the Zuni Kidney Project.

Authors:  Guenet H Degaffe; David L Vander Jagt; Arlene Bobelu; Jeanette Bobelu; Donica Neha; Mildred Waikaniwa; Philip Zager; Vallabh O Shah
Journal:  J Diabetes Complications       Date:  2008-04-16       Impact factor: 2.852

2.  Role for glyoxalase I in Alzheimer's disease.

Authors:  Feng Chen; M Axel Wollmer; Frederic Hoerndli; Gerald Münch; Björn Kuhla; Evgeny I Rogaev; Magdalini Tsolaki; Andreas Papassotiropoulos; Jürgen Götz
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-05       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.